Orthopediatrics (KIDS) Income from Continuing Operations (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Income from Continuing Operations came in at 10687000.0 in Q1 2026, little changed year-on-year from 10715147.49 in Q1 2025, and down 5.78% on a QoQ basis from 10103000.0 in Q4 2025.
Orthopediatrics (KIDS) Income from Continuing Operations (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Income from Continuing Operations data on file, last reported at 10687000.0 in Q1 2026.
- On a quarterly basis, Income from Continuing Operations changed 0.26% year-over-year to 10687000.0 in Q1 2026; TTM through Mar 2026 was 39676000.0, a 2.46% increase from a year earlier, with the FY2025 full-year figure at 39648000.0, down 4.83% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 10687000.0, down from 10103000.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for KIDS reached as high as 18539000.0 in Q3 2022 and fell as low as 16069000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 6345470.59 across 5 years, with a median of 7805000.0 in 2024.
- On a YoY basis, Income from Continuing Operations climbed as much as 943.83% in 2022 and fell as far as 11000.0% in 2022.
- Year by year, Income from Continuing Operations stood at 7848000.0 in 2022, then advanced by 14.74% to 6691000.0 in 2023, then slumped by 140.16% to 16069000.0 in 2024, then surged by 37.13% to 10103000.0 in 2025, then dropped by 5.78% to 10687000.0 in 2026.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 10687000.0 in Q1 2026, 10103000.0 in Q4 2025, and 11773000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 199.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 273.95 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Orthopediatrics | 443.38 Mn | 429.14 Mn | 43.39 Mn | -10.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.69 Mn |
| Dec 31, 2025 | -10.10 Mn |
| Sep 30, 2025 | -11.77 Mn |
| Jun 30, 2025 | -7.11 Mn |
| Mar 31, 2025 | -10.66 Mn |
| Dec 31, 2024 | -16.07 Mn |
| Sep 30, 2024 | -7.92 Mn |
| Jun 30, 2024 | -6.03 Mn |
| Mar 31, 2024 | -7.81 Mn |
| Dec 31, 2023 | -6.69 Mn |
| Sep 30, 2023 | -4.59 Mn |
| Jun 30, 2023 | -2.89 Mn |
| Mar 31, 2023 | -6.81 Mn |
| Dec 31, 2022 | -7.85 Mn |
| Sep 30, 2022 | 18.54 Mn |
| Jun 30, 2022 | -333,000.00 |
| Mar 31, 2022 | -9.10 Mn |
| Dec 31, 2021 | 72,000.00 |
| Sep 30, 2021 | -2.20 Mn |
| Jun 30, 2021 | -3.76 Mn |